Ab&b Bio-tech Co., Ltd.js

This phase 3 trial is testing whether simpler vaccination schedules for rabies are as effective as the standard 5-dose regimen. About 3,000 healthy people aged 10 to 60 will receive the vaccine in different patterns, including fewer total doses. Researchers will measure immune re…

This study tests a new shingles vaccine in 960 healthy adults aged 40 and older. The goal is to see if it is safe and triggers a strong immune response. Researchers will monitor side effects and measure antibody levels over time. This is an early-stage trial to help develop a bet…

This early-stage trial is testing whether a new flu vaccine with an adjuvant (a booster ingredient) is safe for adults aged 65 and older. Eighty volunteers will receive a single shot and be monitored for side effects over a year. The study does not yet test if the vaccine prevent…

This early-stage trial is testing the safety of a new quadrivalent influenza vaccine with an adjuvant (a booster ingredient) in adults aged 65 and older. Eighty participants will receive either the new vaccine, a standard flu vaccine, or a placebo. The study monitors side effects…